Lyell Immunopharma, Inc. (LYEL)
19.12
-1.65
(-7.94%)
USD |
NASDAQ |
Mar 20, 16:00
19.07
-0.05
(-0.26%)
After-Hours: 20:00
Lyell Immunopharma EPS Diluted (Quarterly) : -6.622 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| Nektar Therapeutics | -1.778 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| SELLAS Life Sciences Group, Inc. | -0.05 |
| Fortress Biotech, Inc. | 0.111 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -140.72M |
| Revenue (Quarterly) | 0.006M |
| Total Expenses (Quarterly) | 140.73M |
| Enterprise Value | 86.90M |
| Gross Profit Margin (Quarterly) | -39.85K% |
| Profit Margin (Quarterly) | -2.35M% |
| Earnings Yield | -61.77% |
| Normalized Earnings Yield | -54.00 |